Learn how to get your prescriptions transferred and filled when you’re forced to leave your home with little or no warning ...

It’s the sort of injury that will make you suspicious of sex toys for a long time. The internet has caught wind of a ...

A Tennessee man accused of creating and selling unapproved drugs for use in bodybuilding from his Kalispell business has ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novartis faces short-term challenges with patent expirations but shows long-term growth potential, making the stock a buy ...

If tech evangelists are right, the technology will become ubiquitous -- and profitable. The investment firm Bessemer Venture Partners has identified some 20 health-focused AI startups on track to make ...

QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...

Facing personnel shortages and pandemic disruptions, the U.S. Food and Drug Administration has failed to meet requirements ...

The drugs are listed in alphabetical order. Adalimumab-Adbm injection: Boehringer Ingelheim Pharmaceuticals discontinued two presentations of Cyltezo, its biosimilar to Humira. The injectable ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Ventris Medical’s Backpack (Porous Biologic ...